No IGF-1 or glucose disruption: Unlike HGH, AOD-9604 does not significantly increase IGF-1 or negatively affect insulin sensitivity, making it a safer candidate for metabolic regulation Benefits of AOD-9604 When dosed consistently, AOD-9604 provides targeted fat-burning and metabolic support without the systemic hormonal risks seen with full-length HGH
B.RasicZ.SeverM.DrmicD.et al (2016)
Some people may start with weekly injections to jump-start their metabolism and fat-burning processes, then reduce the frequency as they progress toward their goals
Video Section Recent Articles
Emerging research and real-world experience suggest GLP-1 meds help reduce flares, pain, and inflammation in various inflammatory and autoimmune diseases, especially when obesity or insulin resistance is also present. What are the current barriers to getting GLP-1 medications (cost, coverage)
A purity claim with no HPLC chart or named lab